prenalterol has been researched along with 1-methyl-3-isobutylxanthine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, U; Wesslau, C | 1 |
| Kenakin, TP; Scott, DL | 1 |
| Beek, D; Kenakin, TP | 1 |
3 other study(ies) available for prenalterol and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Alprenolol; Animals; Cyclic AMP; GTP-Binding Proteins; Isoproterenol; Lipolysis; Male; Pertussis Toxin; Pindolol; Prenalterol; Rats; Rats, Sprague-Dawley; Terbutaline; Virulence Factors, Bordetella | 1992 |
A method to assess concomitant cardiac phosphodiesterase inhibition and positive inotropy.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Monophosphate; Animals; Cardiotonic Agents; Guinea Pigs; Heart; In Vitro Techniques; Models, Biological; Phosphodiesterase Inhibitors; Prenalterol; Receptors, Adrenergic, beta | 1987 |
The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Practolol; Prenalterol; Receptors, Adrenergic, beta; Regression Analysis | 1984 |